For many adults with ADHD, the journey to diagnosis and treatment is long enough, so when your GP refuses a Shared Care Agreement (SCA), it can feel like the system is shutting the door just when you finally reached stability. Across the UK, GP refusals have become increasingly common, leaving thousands of patients stuck paying for private prescriptions or facing medication gaps.
If your GP has rejected shared care, here’s what happens, why it’s happening, and how DoseDirect’s private ADHD medication service can keep your treatment stable without relying on GP acceptance.
What a Shared Care Agreement Is and Why It Matters
A Shared Care Agreement is a voluntary arrangement between your ADHD specialist and your GP. After diagnosis and titration, the specialist asks your GP to take over prescribing and routine monitoring. This is what normally transitions you from private prescriptions to standard NHS prescription charges.
But here’s the crucial part: Shared care is voluntary. GPs are not contractually required to accept it.
This is where many patients hit a wall.
Why GPs Reject Shared Care
GP refusals are rarely personal. They’re usually driven by:
- Indemnity concerns around prescribing controlled ADHD medicines initiated privately
- Workload pressures, especially for practices already stretched
- Non-core service status shared care is optional under NHS contracts
- Concerns about private ADHD clinics and diagnostic variation
- Local ICB policies restricting or discouraging shared care with private providers
The result? Even with a valid diagnosis and stable medication, your GP may decline to take over prescribing.
What Happens When Shared Care Is Refused
- Your prescribing stays private
Your specialist remains responsible for issuing prescriptions and monitoring. This means ongoing private costs.
- You may experience medication gaps
If your private provider cannot issue prescriptions quickly, or if you expected your GP to continue prescribing, you may temporarily lose access.
- You must continue paying for private reviews
Most private clinics require periodic paid reviews to maintain prescribing.
- You can request the refusal in writing
GPs must provide a clinical or policy reason for declining shared care.
Your Rights When Shared Care Is Refused
You can:
- Request the practice’s shared-care policy
- Ask your Integrated Care Board (ICB) for its ADHD shared-care position
- Escalate concerns to NHS England or the Parliamentary and Health Service Ombudsman
- Switch GP practices (though many follow similar policies)
- Consider NHS Right to Choose pathways where available
But while these routes can help, they don’t solve the immediate problem: you still need safe, continuous access to your medication.
How DoseDirect Supports Patients When Shared Care Is Refused
This is where DoseDirect’s model is uniquely helpful.
DoseDirect’s ADHD service is specifically designed to continue your ADHD medication safely and privately, without relying on GP shared care acceptance.
✔ No shared-care agreement required
DoseDirect’s pharmacist independent prescribers can take over your ADHD medication management even if your GP refuses shared care.
✔ Support for titration, restarting treatment, or transferring care
Whether you’re stabilising your dose, restarting after a break, or transferring from another provider, DoseDirect can review your diagnostic documentation and treatment history.
✔ Structured, clinician-led ADHD medication management
Your care is delivered by UK pharmacist prescribers who follow current clinical guidance and provide ongoing monitoring.
✔ Clear pricing and no hidden membership fees
Medication is supplied via private prescription with transparent costs.
✔ Ongoing access to the pharmacy team
You’re not left on your own, DoseDirect provides continuous clinical support, follow-up, and monitoring.
✔ Travel letters and documentation available
Useful for work, travel, or continuity of care.
Explore the full ADHD service here:
Why DoseDirect Is a Lifeline for Patients Stuck Without Shared Care
When GP shared care is refused, most patients face:
- High private prescription costs
- Delays in accessing medication
- Uncertainty about who is responsible for prescribing
- Stress around maintaining treatment stability
DoseDirect removes these barriers by providing a stable, clinician-led private pathway that keeps you medicated, monitored, and supported, without needing GP approval.
This makes DoseDirect one of the few UK services that can genuinely bridge the gap created by shared-care refusals.
Key Takeaways
- GP shared care is voluntary, refusals are increasingly common.
- When refused, prescribing stays private, often causing medication gaps.
- You can request written reasons and escalate concerns, but these processes take time.
- DoseDirect can continue your ADHD medication safely without shared-care acceptance.
- You receive structured clinical review, ongoing support, and transparent pricing.
Ready to Keep Your ADHD Treatment Stable?
If your GP has refused shared care, or you’re worried they might, DoseDirect can provide safe, continuous ADHD medication management from qualified UK pharmacist prescribers.
Explore ADHD Care at DoseDirect
Start your clinical questionnaire
Transfer your treatment safely and securely
Clinically reviewed by Daniel Chalmers MPharm, MAPCPharm, independent prescriber and superintendent pharmacist specialising in ADHD and weight loss, GPhC 2222680. Last reviewed 14/09/2026
